<VariationArchive VariationID="6013" VariationName="NM_003924.4(PHOX2B):c.676del (p.Ala226fs)" VariationType="Deletion" Accession="VCV000006013" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2018-02-23" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21052" VariationID="6013">
      <GeneList>
        <Gene Symbol="PHOX2B" FullName="paired like homeobox 2B" GeneID="8929" HGNC_ID="HGNC:9143" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="41744082" stop="41748725" display_start="41744082" display_stop="41748725" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="41746098" stop="41750986" display_start="41746098" display_stop="41750986" Strand="-" />
          </Location>
          <OMIM>603851</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003924.4(PHOX2B):c.676del (p.Ala226fs)</Name>
      <CanonicalSPDI>NC_000004.12:41746075:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="41746076" stop="41746076" display_start="41746076" display_stop="41746076" variantLength="1" positionVCF="41746075" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="41748093" stop="41748093" display_start="41748093" display_stop="41748093" variantLength="1" positionVCF="41748092" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A226fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.41748097del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.41748097del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.41746080del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.41746080del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008243.1" sequenceAccession="NG_008243" sequenceVersion="1" change="g.7895del">
            <Expression>NG_008243.1:g.7895del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_053075.1" sequenceAccession="NG_053075" sequenceVersion="1" change="g.206del">
            <Expression>NG_053075.1:g.206del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003924.3" sequenceAccession="NM_003924" sequenceVersion="3" change="c.672delG">
            <Expression>NM_003924.3:c.672delG</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003915.2" sequenceAccession="NP_003915" sequenceVersion="2" change="p.Ala226Argfs">
            <Expression>NP_003915.2:p.Ala226Argfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003924.4" sequenceAccession="NM_003924" sequenceVersion="4" change="c.676del" MANESelect="true">
            <Expression>NM_003924.4:c.676del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003915.2" sequenceAccession="NP_003915" sequenceVersion="2" change="p.Ala226fs">
            <Expression>NP_003915.2:p.Ala226fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_513" sequenceAccession="LRG_513">
            <Expression>LRG_513:g.7895del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_513t1" sequenceAccession="LRG_513t1">
            <Expression>LRG_513t1:c.676del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003924.3" sequenceAccession="NM_003924" sequenceVersion="3" change="c.676delG">
            <Expression>NM_003924.3:c.676delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603851.0007" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003924.4(PHOX2B):c.676del (p.Ala226fs) AND Hirschsprung disease-ganglioneuroblastoma syndrome" Accession="RCV000006384" Version="3">
        <ClassifiedConditionList TraitSetID="1667">
          <ClassifiedCondition DB="MedGen" ID="C5191058">Hirschsprung disease-ganglioneuroblastoma syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2004-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003924.4(PHOX2B):c.676del (p.Ala226fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002362567" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-18" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-02-23" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11953745</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12438263</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15338462</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17637745</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20089899</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23754957</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23873030</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1667" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6350" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hirschsprung disease ganglioneuroblastoma</ElementValue>
                <XRef ID="Hirschsprung+disease+ganglioneuroblastoma/3422" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neuroblastoma with Hirschsprung disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hirschsprung disease-ganglioneuroblastoma syndrome</ElementValue>
                <XRef ID="MONDO:0013082" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2695" />
                <XRef ID="2695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="2151" DB="Orphanet" />
              <XRef ID="C5191058" DB="MedGen" />
              <XRef ID="MONDO:0013082" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26566" SubmissionDate="2018-02-20" DateLastUpdated="2018-02-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603851.0007_NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE" title="PHOX2B, 1-BP DEL, 676G_NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE" />
        <ClinVarAccession Accession="SCV000026566" DateUpdated="2018-02-23" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a family previously described by Maris et al. (2002) in which 7 members spanning 3 generations had neuroblastoma (613013), 2 of whom also had Hirschsprung disease (142623), Mosse et al. (2004) identified a heterozygous 1-bp deletion in the PHOX2B gene, 676delG, resulting in a frameshift and a slightly truncated protein lacking the second polyalanine tract. The mutation segregated with neuroblastoma through all 3 generations. The family had previously been shown to cosegregate a 16p13-p12 haplotype with neuroblastoma. The proband, who was affected with neuroblastoma, Hirschsprung disease, and neurofibromatosis type I (162200), had previously been shown to have an inactivating mutation in the NF1 gene, 3775delT (613113.0037), which was not present in either parent. Mosse et al. (2004) concluded that the presence of 2 germline mutations in the proband, as well as evidence of linkage to 16p in the family, suggested an oligogenic mechanism for neuroblastoma initiation, as had been shown for other diseases of neural crest-derived tissues (Gabriel et al., 2002).</Attribute>
              <Citation>
                <ID Source="PubMed">12438263</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15338462</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11953745</ID>
              </Citation>
              <XRef DB="OMIM" ID="613013" Type="MIM" />
              <XRef DB="OMIM" ID="142623" Type="MIM" />
              <XRef DB="OMIM" ID="162200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHOX2B" />
          </GeneList>
          <Name>PHOX2B, 1-BP DEL, 676G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 676G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603851.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5149160" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8298859|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002661692" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15338462</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17637745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20089899</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23754957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23873030</ID>
          </Citation>
          <Comment>The c.676delG pathogenic mutation, located in coding exon 3 of the PHOX2B gene, results from a deletion of one nucleotide at nucleotide position 676, causing a translational frameshift with a predicted alternate stop codon (p.A226Rfs*83). This alteration occurs at the 3' terminus of thePHOX2B gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 28% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). This variant has been reported to segregate with neuroblastoma in one family, which also had a history of Hirschsprung disease (Mosse YP et al. Am J Hum Genet, 2004 Oct;75:727-30). Functional studies have shown that this alteration impairs the trans-activation activity of PHOX2B and may disrupt the proliferation and differentiation of neural cells (Raabe EH et al. Oncogene, 2008 Jan;27:469-76; Reiff T et al. J Neurosci, 2010 Jan;30:905-15; Pei D et al. PLoS Genet, 2013 Jun;9:e1003533; Wang W et al. Oncogene, 2014 Jun;33:3316-24). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHOX2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003924.3:c.676delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26566" TraitType="Disease" MappingType="Name" MappingValue="NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE" MappingRef="Preferred">
        <MedGen CUI="C5191058" Name="Hirschsprung disease-ganglioneuroblastoma syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5149160" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

